Share Twitter LinkedIn Facebook Email Michael Davidson, M.D., Royal Marsden Hospital, discusses Gender Differences: Gastric & Esophageal Cancer Treatment. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
SGNTUC-024 Phase 1b/2 study: Tucatinib, trastuzumab, FOLFOX for HER2+ GI cancers Gastrointestinal 8 Mins Read